Validation of Progranulin as a Biomarker for Sepsis
NCT03280576 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 556
Last updated 2019-08-15
Summary
Progranulin blood concentrations in patients with sepsis will be analysed in relation to disease status in order to validate progranulin as a biomarker for sepsis. Patients undergoing cardiac surgery will serve as controls.
Conditions
Sponsors & Collaborators
-
City of Munich
collaborator OTHER_GOV -
Ludwig-Maximilians - University of Munich
lead OTHER
Principal Investigators
-
Gustav Schelling, M.D. · Department of Anaesthesiology LMU
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2019-04-30
- Completion
- 2019-06-30
Countries
- Germany
Study Locations
More Related Trials
-
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
NCT02803346 ·Status: UNKNOWN
-
Pharmacogenomic Biomarker Study for Recombinant Human Activated Protein C Treatment in Severe Sepsis
NCT01486524 ·Status: UNKNOWN
-
Value of Laboratory Biomarkers in Prediction of Outcome in Septic Patients
NCT06338124 ·Status: RECRUITING
-
Application of Stimulated Immune Response Change to Predict Outcome of Patient With Severe Sepsis
NCT02887274 ·Status: UNKNOWN
-
CRP Versus PCT as Bio-markers for Sepsis and in Guiding Antibiotics in Critically Ill Patients
NCT04049565 ·Status: COMPLETED
-
Molecular Biomarkers for Sepsis
NCT04280354 ·Status: TERMINATED
-
Identification of Cardiovascular and Molecular Prognostic Factors for the Mid- and Long-term Outcome of Sepsis
NCT03620409 ·Status: COMPLETED
-
Next-Generation Sequencing Diagnostics of Bacteremia in Sepsis
NCT03356249 ·Status: COMPLETED
-
CRP and PCT as Predictors of Sepsis Cause
NCT05605275 ·Status: COMPLETED
-
Molecular Diagnosis and Risk Stratification of Sepsis
NCT01905033 ·Status: UNKNOWN
-
Validation of Molecular and Protein Biomarkers in Sepsis
NCT04289506 ·Status: UNKNOWN
-
Diagnostic Accuracy in Sepsis
NCT03956043 ·Status: COMPLETED
-
A Study to Learn About the Occurrence of Disseminated Intravascular Coagulation in People With Sepsis and Further Worsening of Sepsis
NCT06986798 ·Status: COMPLETED ·Phase: NA
-
Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis
NCT01746407 ·Status: COMPLETED
-
Platelet Reactivity in Septic Shock
NCT03716310 ·Status: COMPLETED
-
A Study on How the Immune System Responds to Sepsis and Its Long-term Effects
NCT07273344 ·Status: RECRUITING
-
Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient
NCT04105400 ·Status: UNKNOWN
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
Novel Sepsis Sub-phenotypes Based on Trajectories of Vital Signs
NCT05826223 ·Status: COMPLETED
-
Clinical Evaluation of Novel Biomarkers in Patients With Septicemia
NCT01359891 ·Status: COMPLETED
-
Does Serum Procalcitonin Levels Predict Sepsis in Patients Undergoing Cytoreductive Surgery
NCT02189434 ·Status: COMPLETED
-
Identification of Markers of Poor Clinical Prognosis in Sepsis by Epigenetic Analysis
NCT06446947 ·Status: RECRUITING
-
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis
NCT00222222 ·Status: COMPLETED ·Phase: NA
-
Hepcidin: a Prognostic Marker of Morbidity and Mortality in Severe Sepsis?
NCT03682003 ·Status: UNKNOWN
-
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
NCT05229328 ·Status: UNKNOWN